Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Lancet (London, England).
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
American Journal of Cardiology.
Microvascular effects of intensive blood pressure control and its relation to glycemic control in the ACCORD blood pressure trial
Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]
Map of science